Diabetes 50:12-17, 2001
© 2001 by the American Diabetes Association, Inc.
Chronic Treatment With 5-Aminoimidazole-4-Carboxamide-1-ß-D-Ribofuranoside Increases Insulin-Stimulated Glucose Uptake and GLUT4 Translocation in Rat Skeletal Muscles in a Fiber TypeSpecific Manner
Esben S. Buhl,
Niels Jessen,
Ole Schmitz,
Steen B. Pedersen,
Oluf Pedersen,
Geoffrey D. Holman, and
Sten Lund
From the Medical Research Laboratory and Medical Department M
(Endocrinology and Diabetes) (E.S.B., N.J., O.S., S.L.), Aarhus
Kommune-hospital; the Department of Endocrinology and Internal Medicine
(S.B.P.), Aarhus Amtssygehus, Aarhus University Hospital; the Institute of
Clinical Pharmacology (O.S.), University of Aarhus, Aarhus; the Steno Diabetes
Centre and Hagedorn Research Institute (O.P.), Gentofte, Copenhagen, Denmark;
and the Department of Biology and Biochemistry (G.D.H.), University of Bath,
Claverton Down, U.K.
Address correspondence and reprint requests to Sten Lund, MD, Medical
Department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus
Kommunehospital, DK-8000 Aarhus C, Denmark. E-mail:
sl{at}dadlnet.dk
.
Recent studies have demonstrated that chronic administration of AICAR
(5-aminoimidazole-4-carboxamide-1-ß-D-ribofuranoside), an activator of
the AMP-activated protein kinase, increases hexokinase activity and the
contents of total GLUT4 and glycogen in rat skeletal muscles. To explore
whether AICAR also affects insulin-stimulated glucose transport and GLUT4 cell
surface content, Wistar rats were subcutaneously injected with AICAR for 5
days in succession (1 mg/g body wt). Maximally insulin-stimulated (60 nmol/l)
glucose uptake was markedly increased in epitrochlearis (EPI) muscle (average
63%, P < 0.001, n = 18-19) and in extensor digitorum
longus muscle (average 26%, P < 0.001, n = 26-30). In
contrast, administration of AICAR did not maximally influence
insulin-stimulated glucose transport in soleus muscle. Studies of EPI muscle
with the
4,4'-O-[2-[2-[2-[2-[2-[6-(biotinylamino)hexanoyl]amino]ethoxy]ethoxy]ethoxy]-4-(1-azi-2,2,2,-trifluoroethyl)benzoyl]amino-1,3-propanediyl]bis-D-mannose
photolabeling technique showed a concomitant increase (average 68%, P
< 0.02) in cell surface GLUT4 content after insulin exposure in
AICAR-injected rats when compared with controls. In conclusion, 5 days of
AICAR administration induces a pronounced fiber type-specific increase in
insulin-stimulated glucose uptake and GLUT4 cell surface content in rat
skeletal muscle with the greatest effect observed on white fast-twitch
glycolytic muscles (EPI). These results are comparable with the effects of
chronic exercise training, and it brings the AMP-activated protein kinase into
focus as a new interesting target for future pharmacological intervention in
insulin-resistant conditions.
Abbreviations:
3-OMG, 3-O-methylglucose; AEBSF, 4-(2-aminoethyl)-benzenesulfonyl fluoride, hydrochloride; AICAR, 5-aminoimidazole-4-carboxamide-1-ß-D-ribofuranoside; AMPK, AMP-activated protein kinase; Bio-LC-ATB-BMPA, 4,4'-O-[2-[2-[2-[2-[2-[6-(biotinylamino) hexanoyl]amino]ethoxy]ethoxy]ethoxy]-4-(1-azi-2,2,2,-trifluoroethyl)benzoyl]amino-1,3-propanediyl]bis-D-mannose; BSA, bovine serum albumin; EDL, extensor digitorum longus; EPI, epitrochlearis; FG, fast-twitch glycolytic; FOG, fast-twitch oxidative glycolytic; HES, hetastarch in saline; KHBB, Krebs-Henseleit bicarbonate buffer; LCFA, long-chain fatty acid; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; RG, red part of the gastrocnemius; SO, slow oxidative; WG, white part of the gastrocnemius

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Sanders, Z. S. Ali, B. D. Hegarty, R. Heath, M. A. Snowden, and D. Carling
Defining the Mechanism of Activation of AMP-activated Protein Kinase by the Small Molecule A-769662, a Member of the Thienopyridone Family
J. Biol. Chem.,
November 9, 2007;
282(45):
32539 - 32548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Putman, K. J. B. Martins, M. E. Gallo, G. D. Lopaschuk, J. A. Pearcey, I. M. MacLean, R. J. Saranchuk, and D. Pette
{alpha}-Catalytic subunits of 5'AMP-activated protein kinase display fiber-specific expression and are upregulated by chronic low-frequency stimulation in rat muscle
Am J Physiol Regulatory Integrative Comp Physiol,
September 1, 2007;
293(3):
R1325 - R1334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Kim, S.-N. Jung, K. H. Son, S. R. Kim, T. Y. Ha, M. G. Park, I. G. Jo, J. G. Park, W. Choe, S.-S. Kim, et al.
Antidiabetes and Antiobesity Effect of Cryptotanshinone via Activation of AMP-Activated Protein Kinase
Mol. Pharmacol.,
July 1, 2007;
72(1):
62 - 72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Miyamoto, T. Toyoda, T. Hayashi, S. Yonemitsu, M. Nakano, S. Tanaka, K. Ebihara, H. Masuzaki, K. Hosoda, Y. Ogawa, et al.
Effect of acute activation of 5'-AMP-activated protein kinase on glycogen regulation in isolated rat skeletal muscle
J Appl Physiol,
March 1, 2007;
102(3):
1007 - 1013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Jorgensen, J. T. Treebak, B. Viollet, P. Schjerling, S. Vaulont, J. F. P. Wojtaszewski, and E. A. Richter
Role of AMPK{alpha}2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle
Am J Physiol Endocrinol Metab,
January 1, 2007;
292(1):
E331 - E339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Suwa, T. Egashira, H. Nakano, H. Sasaki, and S. Kumagai
Metformin increases the PGC-1{alpha} protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo
J Appl Physiol,
December 1, 2006;
101(6):
1685 - 1692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fediuc, M. P. Gaidhu, and R. B. Ceddia
Inhibition of Insulin-Stimulated Glycogen Synthesis by 5-Aminoimidasole-4-Carboxamide-1-{beta}-D-Ribofuranoside-Induced Adenosine 5'-Monophosphate-Activated Protein Kinase Activation: Interactions with Akt, Glycogen Synthase Kinase 3-3{alpha}/{beta}, and Glycogen Synthase in Isolated Rat Soleus Muscle
Endocrinology,
November 1, 2006;
147(11):
5170 - 5177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Fujii, N. Jessen, and L. J. Goodyear
AMP-activated protein kinase and the regulation of glucose transport
Am J Physiol Endocrinol Metab,
November 1, 2006;
291(5):
E867 - E877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fosgerau, C. Fledelius, K. E Pedersen, J. B Kristensen, J. R Daugaard, M. A Iglesias, E. W Kraegen, and S. M Furler
Oral administration of glucose promotes intracellular partitioning of fatty acid toward storage in white but not in red muscle.
J. Endocrinol.,
September 1, 2006;
190(3):
651 - 658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Greenberg, M. J. Jurczak, A. M. Danos, and M. J. Brady
Glycogen branches out: new perspectives on the role of glycogen metabolism in the integration of metabolic pathways
Am J Physiol Endocrinol Metab,
July 1, 2006;
291(1):
E1 - E8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. O. Eijnde, W. Derave, J. F. P. Wojtaszewski, E. A. Richter, and P. Hespel
AMP kinase expression and activity in human skeletal muscle: effects of immobilization, retraining, and creatine supplementation
J Appl Physiol,
April 1, 2005;
98(4):
1228 - 1233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pold, L. S. Jensen, N. Jessen, E. S. Buhl, O. Schmitz, A. Flyvbjerg, N. Fujii, L. J. Goodyear, C. F. Gotfredsen, C. L. Brand, et al.
Long-Term AICAR Administration and Exercise Prevents Diabetes in ZDF Rats
Diabetes,
April 1, 2005;
54(4):
928 - 934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Pencek, J. Shearer, R. C. Camacho, F. D. James, D. B. Lacy, P. T. Fueger, E. P. Donahue, W. Snead, and D. H. Wasserman
5-Aminoimidazole-4-Carboxamide-1-{beta}-D-Ribofuranoside Causes Acute Hepatic Insulin Resistance In Vivo
Diabetes,
February 1, 2005;
54(2):
355 - 360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Jessen, C. B. Djurhuus, J. O. L. Jorgensen, L. S. Jensen, N. Moller, S. Lund, and O. Schmitz
Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion
Am J Physiol Endocrinol Metab,
January 1, 2005;
288(1):
E194 - E199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Pedersen, K. Kristensen, P. A. Hermann, J. A. Katzenellenbogen, and B. Richelsen
Estrogen Controls Lipolysis by Up-Regulating {alpha}2A-Adrenergic Receptors Directly in Human Adipose Tissue through the Estrogen Receptor {alpha}. Implications for the Female Fat Distribution
J. Clin. Endocrinol. Metab.,
April 1, 2004;
89(4):
1869 - 1878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Frosig, S. B. Jorgensen, D. G. Hardie, E. A. Richter, and J. F. P. Wojtaszewski
5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle
Am J Physiol Endocrinol Metab,
March 1, 2004;
286(3):
E411 - E417.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Mahlapuu, C. Johansson, K. Lindgren, G. Hjalm, B. R. Barnes, A. Krook, J. R. Zierath, L. Andersson, and S. Marklund
Expression profiling of the {gamma}-subunit isoforms of AMP-activated protein kinase suggests a major role for {gamma}3 in white skeletal muscle
Am J Physiol Endocrinol Metab,
February 1, 2004;
286(2):
E194 - E200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Terada and I. Tabata
Effects of acute bouts of running and swimming exercise on PGC-1{alpha} protein expression in rat epitrochlearis and soleus muscle
Am J Physiol Endocrinol Metab,
February 1, 2004;
286(2):
E208 - E216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Lihn, B. Richelsen, S. B. Pedersen, S. B. Haugaard, G. S. Rathje, S. Madsbad, and O. Andersen
Increased expression of TNF-{alpha}, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels
Am J Physiol Endocrinol Metab,
November 1, 2003;
285(5):
E1072 - E1080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Moreno, A. L. Serrano, T. Santalucia, A. Guma, C. Canto, N. J. Brand, M. Palacin, S. Schiaffino, and A. Zorzano
Differential Regulation of the Muscle-specific GLUT4 Enhancer in Regenerating and Adult Skeletal Muscle
J. Biol. Chem.,
October 17, 2003;
278(42):
40557 - 40564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Suwa, H. Nakano, and S. Kumagai
Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles
J Appl Physiol,
September 1, 2003;
95(3):
960 - 968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J.F.P. Luiken, S. L.M. Coort, J. Willems, W. A. Coumans, A. Bonen, G. J. van der Vusse, and J. F.C. Glatz
Contraction-Induced Fatty Acid Translocase/CD36 Translocation in Rat Cardiac Myocytes Is Mediated Through AMP-Activated Protein Kinase Signaling
Diabetes,
July 1, 2003;
52(7):
1627 - 1634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Jessen, R. Pold, E. S. Buhl, L. S. Jensen, O. Schmitz, and S. Lund
Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles
J Appl Physiol,
April 1, 2003;
94(4):
1373 - 1379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. N. Nielsen, K. J. W. Mustard, D. A. Graham, H. Yu, C. S. MacDonald, H. Pilegaard, L. J. Goodyear, D. G. Hardie, E. A. Richter, and J. F. P. Wojtaszewski
5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle
J Appl Physiol,
February 1, 2003;
94(2):
631 - 641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Lihn, T. Ostergard, B. Nyholm, S. B. Pedersen, B. Richelsen, and O. Schmitz
Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients
Am J Physiol Endocrinol Metab,
February 1, 2003;
284(2):
E443 - E448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Kayali, D. A. Austin, and N. J. G. Webster
Rottlerin Inhibits Insulin-Stimulated Glucose Transport in 3T3-L1 Adipocytes by Uncoupling Mitochondrial Oxidative Phosphorylation
Endocrinology,
October 1, 2002;
143(10):
3884 - 3896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Iglesias, J.-M. Ye, G. Frangioudakis, A. K. Saha, E. Tomas, N. B. Ruderman, G. J. Cooney, and E. W. Kraegen
AICAR Administration Causes an Apparent Enhancement of Muscle and Liver Insulin Action in Insulin-Resistant High-Fat-Fed Rats
Diabetes,
October 1, 2002;
51(10):
2886 - 2894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Dohm
Exercise Effects on Muscle Insulin Signaling and Action: Invited Review: Regulation of skeletal muscle GLUT-4 expression by exercise
J Appl Physiol,
August 1, 2002;
93(2):
782 - 787.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Hawley, A. E. Gadalla, G. S. Olsen, and D. G. Hardie
The Antidiabetic Drug Metformin Activates the AMP-Activated Protein Kinase Cascade via an Adenine Nucleotide-Independent Mechanism
Diabetes,
August 1, 2002;
51(8):
2420 - 2425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sakamoto and L. J. Goodyear
Exercise Effects on Muscle Insulin Signaling and Action: Invited Review: Intracellular signaling in contracting skeletal muscle
J Appl Physiol,
July 1, 2002;
93(1):
369 - 383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Musi, M. F. Hirshman, J. Nygren, M. Svanfeldt, P. Bavenholm, O. Rooyackers, G. Zhou, J. M. Williamson, O. Ljunqvist, S. Efendic, et al.
Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes
Diabetes,
July 1, 2002;
51(7):
2074 - 2081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Buhl, N. Jessen, R. Pold, T. Ledet, A. Flyvbjerg, S. B. Pedersen, O. Pedersen, O. Schmitz, and S. Lund
Long-Term AICAR Administration Reduces Metabolic Disturbances and Lowers Blood Pressure in Rats Displaying Features of the Insulin Resistance Syndrome
Diabetes,
July 1, 2002;
51(7):
2199 - 2206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Durante, K. J. Mustard, S.-H. Park, W. W. Winder, and D. G. Hardie
Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles
Am J Physiol Endocrinol Metab,
July 1, 2002;
283(1):
E178 - E186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ai, J. Ihlemann, Y. Hellsten, H. P. M. M. Lauritzen, D. G. Hardie, H. Galbo, and T. Ploug
Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle
Am J Physiol Endocrinol Metab,
June 1, 2002;
282(6):
E1291 - E1300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Aschenbach, M. F. Hirshman, N. Fujii, K. Sakamoto, K. F. Howlett, and L. J. Goodyear
Effect of AICAR Treatment on Glycogen Metabolism in Skeletal Muscle
Diabetes,
March 1, 2002;
51(3):
567 - 573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Paulsen, D. S. Rubink, and W. W. Winder
AMP-activated protein kinase activation prevents denervation-induced decline in gastrocnemius GLUT-4
J Appl Physiol,
November 1, 2001;
91(5):
2102 - 2108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. W. Winder
Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle
J Appl Physiol,
September 1, 2001;
91(3):
1017 - 1028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zheng, P. S. MacLean, S. C. Pohnert, J. B. Knight, A. L. Olson, W. W. Winder, and G. L. Dohm
Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase
J Appl Physiol,
September 1, 2001;
91(3):
1073 - 1083.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|